Imodium 2 mg capsule molli

Imodium is a well-known antidiarrheal medication containing Loperamide hydrochloride. The brand was originally developed by Janssen Pharmaceutica, a company founded by Dr. Paul Janssen in Belgium in 1953. Janssen became a part of the American multinational Johnson & Johnson in 1961.

In recent years, as part of a major corporate restructuring, Johnson & Johnson spun off its consumer health division into a new independent company called Kenvue. As of 2023 and beyond, Kenvue is the ultimate owner of Imodium. While the brand has Belgian roots, it is now part of an American-headquartered global health portfolio. Manufacturing occurs in various international facilities depending on the local market and regulatory requirements.